Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma

By                    

Oncology Letters, Vol. 3, Iss. 5, 2012-01 ,pp. : 1002-1006

Spandidos Publications

Access to resources Recommend Favorite

Cisplatin, Adriamycin, Etoposide, Megestrol Acetate versus Melphalan, 5-Fluorouracil, Medroxyprogesterone Acetate in the Treatment of Endometrial Carcinoma

By Cornelison T.L.   Baker T.R.   Piver S.M.   Driscoll D.L.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 243-248

Academic Press

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Expression Is Not Regulated by Estradiol or Medroxyprogesterone Acetate in Endometrial Carcinoma

By Kim Y.B.   Berek J.S.   Martinez-Maza O.   Satyaswaroop P.G.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 97-100

Academic Press

Access to resources Recommend Favorite

The Effect of Medroxyprogesterone Acetate on Angiogenesis in Complex Endometrial Hyperplasia

By Abulafia O.   Triest W.E.   Adcock J.T.   Sherer D.M.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 193-198

Elsevier

Access to resources Recommend Favorite

Conservative Management of Stage I Endometrial Carcinoma after Surgical Staging

By Straughn J.M.   Huh W.K.   Kelly F.J.   Leath C.A.   Kleinberg M.J.   Hyde J.   Numnum T.M.   Zhang Y.   Soong S.-J.   Austin J.M.   Partridge E.E.   Kilgore L.C.   Alvarez R.D.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 194-200

Elsevier

Access to resources Recommend Favorite